Stressing cancer with spice

A new study reports how an experimental drug agent stops cancer cells from growing. A little over a decade ago, scientists first reported pentagamavumon-1 (PGV-1), an analogue of a molecule found in turmeric and that has been since discovered to have anti-cancer effects. In the new study, tests on cancer cells and animals reveal that these anti-cancer effects come from PGV-1 inhibiting a series of enzymes responsible for the metabolism of reactive oxygen species. This finding is expected to clarify how modifications to PGV-1 will lead to its use for cancer treatment.

Read more

Strategies of a honey bee virus

The Israeli Acute Paralysis Virus is a pathogen that affects honey bees and has been linked to Colony Collapse Disorder, a key factor in decimating the bee population. Researchers have now analyzed in detail how the virus hijacks the cellular protein production machinery and misuses it for its own purposes.

Read more

Biological material boosts solar cell performance

Next-generation solar cells that mimic photosynthesis with biological material may give new meaning to the term 'green technology.' Adding the protein bacteriorhodopsin (bR) to perovskite solar cells boosted the efficiency of the devices in a series of laboratory tests, according to an international team of researchers.

Read more

Single mutation dramatically changes structure and function of bacteria's transporter proteins

Swapping a single amino acid in a simple bacterial protein changes its structure and function, revealing the effects of complex gene evolution, finds a new study. The study — conducted using E. coli bacteria — can help researchers to better understand the evolution of transporter proteins and their role in drug resistance.

Read more

Listening in to how proteins talk and learning their language

A research team has created a third approach to engineering proteins that uses deep learning to distill the fundamental features of proteins directly from their amino acid sequence without the need for additional information.

Read more

Resistance to last resort drug arose in patient over 3 weeks

French investigators have described development of resistance to one of the last resort therapies used to treat extremely drug-resistant Pseudomonas aeruginosa. That resistance arose in a single patient over a scant 22 days. They subsequently identified the single nucleotide mutation in P. aeruginosa that caused the resistance.

Read more